Porcilis APP stimulates the development of active immunity against porcine circovirus type 2 in pigs.
Homogenous, white to nearly white emulsion for injection.
Each dose of 0.2 ml contains:
Porcine circovirus type 2 ORF2 subunit antigen ≥ 1436 AU1
1 Antigenic units as determined in the in vitro potency test (antigenic mass assay).
Indications for use
For the active immunisation of fattening pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. In addition, to reduce loss of daily weight gain and mortality associated with PCV2 infection.
Onset of immunity: 2 weeks after vaccination.
Duration of immunity: 23 weeks after vaccination.
Pigs – meat 0 days
Cardboard box with 1 or 10 glass vials. Glass vial (type I) of 10 ml closed with a nitryl-based rubber stopper and sealed with an aluminium cap.
Cardboard box with 1 or 10 PET vials. PET (polyethylene terephthalate) vial of 20 ml closed with a nitryl-based rubber stopper and sealed with an aluminium cap.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018